Merck (MRK) EBT Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
2,272.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
3,105.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
304.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-4,669.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3,220.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,660.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-3,734.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
377.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-4,669.00 |
| Dec 31, 2025 |
-455.00 |
| Sep 30, 2025 |
1,509.00 |
| Jun 30, 2025 |
88.00 |
| Mar 31, 2025 |
744.00 |
| Dec 31, 2024 |
-222.00 |
| Sep 30, 2024 |
-1,548.00 |
| Jun 30, 2024 |
2,222.00 |
| Mar 31, 2024 |
784.00 |
| Dec 31, 2023 |
926.00 |
| Sep 30, 2023 |
1,045.00 |
| Jun 30, 2023 |
-6,456.00 |
| Mar 31, 2023 |
-664.00 |
| Dec 31, 2022 |
6,160.00 |
| Sep 30, 2022 |
502.00 |
| Jun 30, 2022 |
304.00 |
| Mar 31, 2022 |
221.00 |
| Dec 31, 2021 |
523.00 |
| Sep 30, 2021 |
1,534.00 |
| Jun 30, 2021 |
-487.00 |
| Mar 31, 2021 |
1,471.00 |
| Dec 31, 2020 |
-4,126.00 |
| Sep 30, 2020 |
2,282.00 |
| Jun 30, 2020 |
474.00 |
| Mar 31, 2020 |
1,060.00 |
| Dec 31, 2019 |
-2,280.00 |
| Sep 30, 2019 |
-847.00 |
| Jun 30, 2019 |
1,243.00 |
| Mar 31, 2019 |
1,092.00 |
| Dec 31, 2018 |
1,569.00 |
| Sep 30, 2018 |
89.00 |
| Jun 30, 2018 |
1,169.00 |
| Mar 31, 2018 |
-125.00 |
| Dec 31, 2017 |
-9,467.00 |
| Sep 30, 2017 |
-1,218.00 |
| Jun 30, 2017 |
727.00 |
| Mar 31, 2017 |
86.00 |
| Dec 31, 2016 |
-2,423.00 |
| Sep 30, 2016 |
1,358.00 |
| Jun 30, 2016 |
397.00 |
| Mar 31, 2016 |
291.00 |
| Dec 31, 2015 |
-338.00 |
| Sep 30, 2015 |
449.00 |
| Jun 30, 2015 |
-1,352.00 |
| Mar 31, 2015 |
-672.00 |
| Dec 31, 2014 |
9,982.00 |
| Sep 30, 2014 |
-545.00 |
| Jun 30, 2014 |
353.00 |
| Mar 31, 2014 |
544.00 |
| Dec 31, 2013 |
2,616.00 |
| Sep 30, 2013 |
935.00 |
| Jun 30, 2013 |
37.00 |
| Mar 31, 2013 |
888.00 |
| Dec 31, 2012 |
-11,715.00 |
| Sep 30, 2012 |
919.00 |
| Jun 30, 2012 |
867.00 |
| Mar 31, 2012 |
39.00 |
